Chemist and “semi-recreational” codemonkey Isaac Yonemoto is running a crowdfunding campaign called Project Marilyn to create open sourced, patent-free cancer drugs.
Yonemoto proposes a $75,000 stretch goal to fund an experiment he hopes will prove we can use a compound sequenced from microscopic bug cultures to treat cancer.
It’s a plan that could liberate pharmaceuticals and dramatically lower the cost of anticancer medicine. The global market for these drugs surpassed $1 trillion this year. The average monthly cost of a brand-name cancer drug in the U.S. is about $10,000, according to the IMS Institute for Healthcare Informatics.
(Score: 2) by frojack on Tuesday October 28 2014, @11:59PM
talk about getting funding for doing the actual clinical trials that will (potentially) bring this specific (non-patent-encumbered) drug to market.
And there's the rub.
Second or third rate drug companies might produce it, just as they do Aspirin, but nobody is going to make a huge investment in this when some factory in India can take their market away two weeks after they launch.
I know a researcher in breast cancer on the East coast who has the same problem. A drug in hand that they are very confident of, but, because it is naturally produced in the body under certain conditions, there are no interested producers to fund the trials.
No, you are mistaken. I've always had this sig.